With ketamine, Now we have a drug that has unclear success with some quite properly described dose-response and cumulative adverse outcomes that run the many way up to Dying. There is a remarkable dearth of proof of effectively managed, randomized, blinded trials, which seriously stand for the gold common for how we assess effectiveness.Elke dag zi